Abstract
Due to an increasing demand for effective anti-cancer drugs, an oxopyrrolidine-based ligand, sodium 1-(3-(2-aminoethylamino)propyl)-5-oxopyrrolidine-2-carboxylate, was synthesised by the sodium hydride-assisted coupling of pyroglutamic acid with 1,3-diiodopropane under a nitrogen atmosphere. The intermediate thus formed was allowed to react with ethylenediamine in acetonitrile. The ligand formed individual complexes with Cu(II) and Ni(II) metal ions, respectively. The complexes were relatively resistant to degradation in PBS at physiological pH. The DNA-binding constants (K b) for the ligand, copper and nickel complexes were 2.09 × 104 M-1, 2.37 × 104 M-1 and 2.11 × 104 M-1, respectively, revealing the strong binding of these complexes with DNA. Haemolysis assays indicated that the ligand and its complexes were less toxic to rabbit RBCs than doxorubicin. Lipinski’s parameters calculated for the reported compounds indicated their good oral bioavailability. All the compounds exhibited good activities towards MCF-7 (wild type) cancer cell lines. The results of in silico studies, DNA-binding and anti-cancer activities indicated that the reported compounds might be interacting with DNA as one of their possible mechanisms of action.
Similar content being viewed by others
References
Abdel-Rahman, L. H., Battaglia, L. P., & Mahmoud, M. R. (1996). Synthesis, characterization and stability constant determination of l-phenylalanine ternary complexes of cobalt(II), nickel(II), copper(II) with N-heterocyclic aromatic bases and X-ray crystal structure of aqua-1,10-phenanthroline-l-phenylalaninato copper(II) perchlorate complex. Polyhedron, 15, 327–334. DOI: 10.1016/0277-5387(95)00157-n.
Ali, I., Rahis-ud-din, Saleem, K., Aboul-Enein, H. Y., & Rather, A. (2011a). Social aspects of cancer genesis. Cancer Therapy, 8, 6–14.
Ali, I., Rahis-ud-din, Salim, K., Rather, M. A., Wani, W. A., & Haque, A. (2011b). Advances in nanodrugs for cancer chemotherapy. Current Cancer Drug Targets, 11, 135–146. DOI: 10.2174/156800911794328493.
Ali, I., Wani, W. A., & Saleem, K. (2011c). Cancer scenario in India with future perspectives. Cancer Therapy, 8, 56–70.
Ali, I., Wani, W. A., Saleem, K., & Haque, A. (2013a). Platinum compounds: A hope for future cancer chemotherapy. Anticancer Agents in Medicinal Chemistry, 13, 296–306. DOI: 10.2174/1871520611313020016.
Ali, I., Wani, W. A., Saleem, K., & Wesselinova, D. (2013b). Syntheses, DNA binding and anticancer profiles of Lglutamic acid ligand and its copper(II) and ruthenium(III) complexes. Medicinal Chemistry, 9, 11–22. DOI: 10.2174/1573406411309010011.
Ali, I., Wani, W. A., Saleem, K., & Hseih, M. F. (2013c). Design and synthesis of thalidomide based dithiocarbamate Cu(II), Ni(II) and Ru(III) complexes as anticancer agents. Polyhedron, 56, 134–143. DOI: 10.1016/j.poly.2013.03.056.
Ali, I., Haque, A., Saleem, K., & Hsieh, M. F. (2013d). Curcumin-I Knoevenagel’s condensates and their Schiff’s bases as anticancer agents: Synthesis, pharmacological and simulation studies. Bioorganic & Medicinal Chemistry, 21, 3808–3820. DOI: 10.1016/j.bmc.2013.04.018.
Arjmand, F., Aziz, M., & Chauhan, M. (2008). Synthesis, spectroscopic studies of new water-soluble Co(II) and Cu(II) macrocyclic complexes of 4,15-bis(2-hydroxyethyl)-2,4,6,13,15,17-hexaazatricyclodocosane: their interaction studies with calf thymus DNA and guanosine 5’ monophosphate. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 61, 265–278. DOI: 10.1007/s10847-008-9417-5.
Arjmand, F., Jamsheera, A., & Mohapatra, D. K. (2013). Synthesis, characterization and in vitro DNA binding and cleavage studies of Cu(II)/Zn(II) dipeptide complexes. Journal of Photochemistry and Photobiology B: Biology, 121, 75–85. DOI: 10.1016/j.jphotobiol.2012.12.009.
ASTM International (2000). Standard practice for assessment of hemolytic properties of materials. ASTM F756-00. West Conshohocken, PA, USA: ASTM. DOI: 10.1520/f0756-00.
Bacac, M., Hotze, A. C. G., van der Schilden, K., Haasnoot, J. G., Pacor, S., Alessio, E., Sava, G., & Reedijk, J. (2004). The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation. Journal of Inorganic Biochemistry, 98, 402–412. DOI: 10.1016/j.jinorgbio.2003.12.003.
Bello, C., Cea, M., Dal Bello, G., Garuti, A., Rocco, I., Cirmena, G., Moran, E., Nahimana, A., Duchosal, M. A., Fruscione, F., Pronzato, P., Grossi, F., Patrone, F., Ballestrero, A., Dupuis, M., Sordat, B., Nencioni, A., & Vogel, P. (2010). Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as α-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. Bioorganic & Medicinal Chemistry, 18, 3320–3334. DOI: 10.1016/j.bmc.2010.03.009.
Buschini, A., Pinelli, S., Pellacani, C., Giordani, F., Ferrari, M. B., Bisceglie, F., Gianetto, M., Pelosi, G., & Tarasconi, P. (2009). Synthesis, characterization and deepening in the comprehension of the biological action mechanisms of a new nickel complex with antiproliferative activity. Journal of Inorganic Biochemistry, 103, 666–677. DOI: 10.1016/j.jinorgbio.2008.12.016.
Chaudhary, A., & Singh, R. V. (2004). Synthetic, spectroscopic and toxicological aspects of novel eighteen to twenty two membered tetraazamacrocycles and their bivalent manganese complexes. Indian Journal of Chemistry, Section A, 43A, 2529–2535.
Chauhan, M., & Arjmand, F. (2006). Chiral and achiral macrocyclic copper(II) complexes: synthesis, characterization, and comparative binding studies with calf-thymus DNA. Chemistry & Biodiversity, 3, 660–676. DOI: 10.1002/cbdv.200690069.
Chen, J. N., Huang, Y. W., Liu, G. S., Afrasiabi, Z., Sinn, E., Padhye, S., & Ma, Y. F. (2004). The cytotoxicity and mechanisms of 1,2-naphthoquinone thiosemicarbazone and its metal derivatives against MCF-7 human breast cancer cells. Toxicology and Appied Pharmacology, 197, 40–48. DOI: 10.1016/j.taap.2004.02.004.
Fiaux, H., Kuntz, D. A., Hoffman, D., Janzer, R. C., Gerber-Lemaire, S., Rose, D. R., & Juillerat-Jeanneret, L. (2008). Functionalized pyrrolidine inhibitors of human type II α-mannosidases as anti-cancer agents: Optimizing the fit to the active site. Bioorganic & Medicinal Chemistry, 16, 7337–7346. DOI: 10.1016/j.bmc.2008.06.021.
Groessl, M., Hartinger, C. G., Dyson, P. J., & Keppler, B. K. (2008). CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP. Journal of Inorganic Biochemistry, 102, 1060–1065. DOI: 10.1016/j.jinorgbio.2007.11.018.
Guo, J., Zhang, Y. J., Zhang, J., Liang, J., Zeng, L. H., & Guo, G. Z. (2012). Anticancer effect of tert-butyl-2(4,5- dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2)-pyrrolidine-1-carboxylic ester on human hepatoma HepG2 cell line. Chemico-Biological Interactions, 199, 38–48. DOI: 10.1016/j.cbi.2012.06.001.
Hsu, C. W., Kuo, C. F., Chuang, S. M., & Hou, M. H. (2013). Elucidation of the DNA-interacting properties and anticancer activity of a Ni(II)-coordinated mithramycin dimer complex. BioMetals, 26, 1–12. DOI: 10.1007/s10534-012-9589-8.
Kemp, W. (1975). Organic spectroscopy. London, UK: Macmillan Press.
Krushna, Ch., Mohapatra, C., & Dash, K. C. (1977). 4-, 5-and 6-coordinate complexes of copper(II) with substituted imidazoles. Journal of Inorganic and Nuclear Chemistry, 39, 1253–1258. DOI: 10.1016/0022-1902(77)80363-1.
Küng, A., Pieper, T., Wissiack, R., Rosenberg, E., & Keppler, B. K. (2001). Hydrolysis of the tumor-inhibiting ruthenium(III) complexes HIm trans-[RuCl4(im)2] and H Ind trans-[RuCl4(ind)2] investigated by means of HPCE and HPLC-MS. Journal of Biological Inorganic Chemistry, 6, 292–299. DOI: 10.1007/s007750000203.
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46, 3–26. DOI: 10.1016/s0169-409x(00)00129-0.
Marmur, J. (1961). Procedure for the isolation of deoxyribonucleic acid from microorganism. Journal of Molecular Biology, 3, 208–218. DOI: 10.1016/s0022-2836(61)80047-8.
Marzano, C., Pellei, M., Tisato, F., & Santini, C. (2009). Copper complexes as anticancer agents. Anti-Cancer Agents in Medicinal Chemistry, 9, 185–211. DOI: 10.2174/187152009787313837.
Mathew, V., Keshavayya, J., Vaidya, V. P., & Khan, M. H. M. (2008). Triazoles as complexing agents: synthesis, characterization and pharmacological activities of copper complexes of 4-amino-3-mercapto-5-substituted aryl-1,2,4- triazoles. Journal of Coordination Chemistry, 61, 2629–2638. DOI: 10.1080/00958970801950615.
Mathur, S., & Tabassum, S. (2008). Template synthesis of novel carboxamide dinuclear copper(II) complex: spectral characterization and reactivity towards calf-thymus DNA. BioMetals, 21, 299–310. DOI: 10.1007/s10534-007-9119-2.
Morris, G. M., Goodsell, G. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19, 1639–1662. DOI: 10.1002/(sici)1096-987x(19981115)19:14〈1639::aid-jcc10〉3.0.co;2-b.
Mosman, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55–63. DOI: 10.1016/0022-1759(83)90303-4.
Muegge, I. (2003). Selection criteria for drug-like compounds. Medicinal Research Reviews, 23, 302–321. DOI: 10.1002/med.10041.
Nakamoto, K. (1970). Infrared spectra of inorganic and coordination compounds. New York, NY, USA: Wiley.
Nogrady, T. (1985). Medicinal chemistry: a biochemical approach. New York, NY, USA: Oxford University press.
Ott, I., & Gust, R. (2007). Non platinum metal complexes as anti-cancer drugs. Archiv der Pharmazie, 340, 117–126. DOI 10.1002/ardp.200600151.
Parveen, S., & Arjmand, F. (2012). De novo design, synthesis and spectroscopic characterization of chiral benzimidazole-derived amino acid Zn(II) complexes: Development of tryptophan-derived specific hydrolytic DNA artificial nuclease agent. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 85, 53–60. DOI: 10.1016/j.saa.2011.09.006.
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF chimera: A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25, 1605–1612. DOI: 10.1002/jcc.20084.
Qu, J. Q., Qu, L., Yang, Q. H., & Wang, L. F. (2009). Synthesis, characterization, and anti-tumor activities of some transition metal(II) complexes with podophyllic acid hydrazide. Chemical Papers, 63, 426–431. DOI: 10.2478/s11696-009-0033-7.
Rau, T., & van Eldik, R. (1996). Metal ions in biological systems. New York, NY, USA: Marcel Dekker.
Refsgaard, H. H. F., Jensen, B. F., Brockhoff, P. B., Padkjær, S. B., Guldbrandt, M., & Christensen, M. S. (2005). In silico prediction of membrane permeability from calculated molecular parameters. Journal of Medicinal Chemistry, 48, 805–811. DOI: 10.1021/jm049661n.
Reichmann, M. F., Rice, S. A., Thomas, C. A., & Doty, P. (1954). A further examination of the molecular weight and size of desoxypentose nucleic acid. Journal of the American Chemical Society, 76, 3047–3053. DOI: 10.1021/ja01640a067.
Ruiz-Azuara, L., & Bravo-Gomez, M. E. (2010). Copper compounds in cancer chemotherapy. Current Medicinal Chemistry, 17, 3606–3615. DOI: 10.2174/092986710793213751.
Saleem, K., Wani, W. A., Haque, A., Lone, M. N., Hsieh, M. F., Jairajpuri, M. A., & Ali, I. (2013). Synthesis, DNA binding, hemolysis assays and anticancer studies of copper(II), nickel(II) and iron(III) complexes of a pyrazoline-based ligand. Future Medicinal Chemistry, 5, 135–146. DOI: 10.4155/fmc.12.201.
Sanner, M. F. (1999). Python: a programming language for software integration and development. Journal of Molecular Graphics & Modelling, 17, 57–61.
Sayes, C. M., Reed, K. L., & Warheit, D. B. (2007). Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicological Sciences, 97, 163–180. DOI: 10.1093/toxsci/kfm018.
Siegel, R., Naishadham, D., & Jemal, A. (2013). Cancer statistics, 2013. CA: A Cancer Journal for Clinicians, 63, 11–30. DOI: 10.3322/caac.21166.
Stephenson, T. A., Morehouse, S. M., Powell, A. R., Heffer, J. P., & Wilkinson, G. (1965). Carboxylates of palladium, platinum, and rhodium, and their adducts. Journal of the Chemical Society, 1965, 3632–3640. DOI: 10.1039/jr9650003632.
Stephenson, T. A., & Wilkinson, G. (1967). Acetato complexes of palladium(II). Journal of Inorganic and Nuclear Chemistry, 29, 2122–2123. DOI: 10.1016/0022-1902(67)80480-9.
Tan, S. J., Yan, Y. K., Lee, P. P. F., & Lim, K. H. (2010a). Copper, gold and silver compounds as potential new antitumor metallodrugs. Future Medicinal Chemistry, 2, 1591–1608. DOI: 10.4155/fmc.10.234.
Tan, J., Zhu, L. C., & Wang, B. (2010b). From GC-rich DNA binding to the repression of survivin gene for quercetin nickel(II) complex: implications for cancer therapy. BioMetals, 23, 1075–1084. DOI: 10.1007/s10534-010-9353-x.
Tan, C. P., Hu, S., Liu, J., & Ji, L. N. (2011). Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium-DMSO complexes containing 2,2’-biimidazole. European Journal of Medicinal Chemistry, 46, 1555–1563. DOI: 10.1016/j.ejmech.2011.01.074.
Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45, 2615–2623. DOI: 10.1021/jm020017n.
Wang, Y., & Yang, Z. Y. (2005). Synthesis, characterization and DNA-binding properties of three 3d transition metal complexes of the Schiff base derived from diethenetriamine with PMBP. Transition Metal Chemistry, 30, 902–906. DOI: 10.1007/s11243-005-6298-y.
Wolfe, A., Shimer, G. H., & Meehan, T. (1987). Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA. Biochemistry, 26, 6392–6296. DOI: 10.1021/bi00394a013.
Xu, Z. D., Liu, H., Xiao, S. L., Yang, M., & Bu, X. H. (2002). Synthesis, crystal structure, antitumor activity and DNA-binding study on the Mn(II) complex of 2H-5-hydroxy-1,2,5-oxadiazo[3,4-f]1,10-phenanthroline. Journal of Inorganic Biochemistry, 90, 79–84. DOI: 10.1016/s0162-0134(02)00416-6.
Zhang, Y. J., Guo, J., Zeng, L. H., Zhang, J., Hui, Y. P., Liu, J. Y., Qing, X. Y., Sun, X. L., & Guo, G. Z. (2011). Tert-butyl-2(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester displays novel cytotoxicity through reactive oxygen species-mediated oxidative damage in MCF-7 and MDAMB-231 cells. Chemico-Biological Interactions, 192, 287–297. DOI: 10.1016/j.cbi.2011.04.006.
Zheng, Y. J., Li, X. W., Li, Y. T., Wu, Z. Y., & Yan, C. W. (2012). Synthesis, structure, anticancer activities, and DNA-binding properties of a 1-D polymeric copper(II) complex alternately bridged by oxamide and terephthalate. Journal of Coordination Chemistry, 65, 3530–3545. DOI: 10.1080/00958972.2012.719609.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Ali, I., Wani, W.A., Saleem, K. et al. Development of oxopyrrolidine-based anti-cancer compounds: DNA binding, in silico, cell line studies, drug-likeness and mechanism at supra-molecular level. Chem. Pap. 68, 540–552 (2014). https://doi.org/10.2478/s11696-013-0486-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11696-013-0486-6